Safety and Tolerability Study for T-1101 (Tosylate) to Treat Advanced Refractory Solid Tumors
Clinical trial NCT03195764 · TERMINATED
Trial details
- NCT number
- NCT03195764
- Sponsor
- Taivex Therapeutics Corporation
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-14
- Primary completion
- 2019-10-01
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.